Search Results - Andrew Rowland
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
Addressing MISEV guidance using targeted LC‐MS/MS: A method for the detection and quantification of extracellular vesicle‐enriched and contaminant protein markers from blood by Lauren A. Newman, Zivile Useckaite, Andrew Rowland
Published in Journal of Extracellular Biology (2022-09-01)Get full text
Article -
4
-
5
Early tumor shrinkage identifies long-term disease control and survival in patients with lung cancer treated with atezolizumab by Andrew Rowland, Ashley M Hopkins, Ganessan Kichenadasse, Chris S Karapetis, Michael J Sorich
Published in Journal for ImmunoTherapy of Cancer (2020-05-01)Get full text
Article -
6
-
7
-
8
Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease by Lauren A. Newman, Zivile Useckaite, Jillian Johnson, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland
Published in Biomedicines (2022-01-01)Get full text
Article -
9
Biodegradation and Detoxification of Some Dyes by Crude Lignin Peroxidase Complex Produced by <i>Escherichia coli</i> Accession No: LR0250096.1 and <i>Pseudomonas aeruginosa</i> Ac... by Sindiswa Lungile Dube, Foluso Oluwagbemiga Osunsanmi, Albert Olufemi Ikhane, Rebamang Anthony Mosa, Andrew Rowland Opoku
Published in Applied Sciences (2024-09-01)Get full text
Article -
10
-
11
Protein Isolate from <i>Parkia biglobosa</i> Seeds Improves Dyslipidaemia and Cardiac Oxidative Stress in Streptozotocin-Induced Diabetic Rats by Bolajoko Idiat Ogunyinka, Babatunji Emmanuel Oyinloye, Foluso Oluwagbemiga Osunsanmi, Unathi Kolanisi, Andrew Rowland Opoku, Abidemi Paul Kappo
Published in Antioxidants (2019-10-01)Get full text
Article -
12
A Lanosteryl Triterpene (RA-3) Exhibits Antihyperuricemic and Nephroprotective Effects in Rats by Nomadlozi Blessings Hlophe, Andrew Rowland Opoku, Foluso Oluwagbemiga Osunsanmi, Trayana Georgieva Djarova-Daniels, Oladipupo Adejumobi Lawal, Rebamang Anthony Mosa
Published in Molecules (2020-09-01)Get full text
Article -
13
Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Su... by Madelé van Dyk, Asha J. Kapetas, Ashley M. Hopkins, A. David Rodrigues, Manoli Vourvahis, Michael J. Sorich, Andrew Rowland
Published in Frontiers in Pharmacology (2019-09-01)Get full text
Article -
14
Observational cohort study with internal and external validation of a predictive tool for identification of children in need of hospital admission from the emergency department: th... by Damian Roland, Calvin Heal, Andrew Rowland, Sarah Cotterill, Steve Woby, Natalie Garratt, Stephen Brown, Tony Long, Laura Jayne Bonnett
Published in BMJ Open (2020-12-01)Get full text
Article -
15
<i>Acanthospermum australe</i> Extract Inhibits the Chaperone Activity of <i>Plasmodium falciparum</i> Heat Shock Protein 70-1 by Ntombikhona Appear Koza, Ntokozo Nkosinathi Myeza, Heinrich Hoppe, Rebamang Anthony Mosa, Abidemi Paul Kappo, Mthokozisi Blessing Cedric Simelane, Andrew Rowland Opoku
Published in Microorganisms (2025-09-01)Get full text
Article -
16
Study of the ketohexokinase inhibitor PF‐06835919 as a clinical cytochrome P450 3A inducer: Integrated use of oral midazolam and liquid biopsy by Ruolun Qiu, Kari Fonseca, Arthur Bergman, Jian Lin, David Tess, Lauren Newman, Alia Fahmy, Zivile Useckaite, Andrew Rowland, Manoli Vourvahis, David Rodrigues
Published in Clinical and Translational Science (2024-01-01)Get full text
Article -
17
Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure by Kenneth H. Wills, Stephen J. Behan, Michael J. Nance, Jessica L. Dawson, Thomas M. Polasek, Ashley M. Hopkins, Madelé van Dyk, Andrew Rowland
Published in Pharmaceutics (2021-12-01)Get full text
Article -
18
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials by Lee X. Li, Mark A. Socinski, Ganessan Kichenadasse, Christos S. Karapetis, Adel Shahnam, Ross A. McKinnon, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich
Published in BMC Cancer (2024-03-01)Get full text
Article -
19
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data by Natansh D. Modi, Jin Quan Eugene Tan, Andrew Rowland, Bogda Koczwara, Ahmad Y. Abuhelwa, Ganessan Kichenadasse, Ross A. McKinnon, Michael D. Wiese, Michael J. Sorich, Ashley M. Hopkins
Published in npj Breast Cancer (2021-03-01)Get full text
Article -
20
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies by Natansh D. Modi, Ganessan Kichenadasse, Tammy C. Hoffmann, Mark Haseloff, Jessica M. Logan, Areti A. Veroniki, Rebecca L. Venchiarutti, Amelia K. Smit, Haitham Tuffaha, Harindra Jayasekara, Arkady Manning-Bennet, Erin Morton, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins
Published in BMC Medicine (2023-10-01)Get full text
Article
